However, it is generally accepted that multiple sclerosis is primarily a Th1 disease, although a recent clinical study has demonstrated that patients with progressive multiple sclerosis as well as relapsing-remitting patients have increased IL-4 levels [27]. This evidence concerns the gene IL4 and multiple sclerosis.